JP2022540396A5 - - Google Patents
Info
- Publication number
- JP2022540396A5 JP2022540396A5 JP2022500119A JP2022500119A JP2022540396A5 JP 2022540396 A5 JP2022540396 A5 JP 2022540396A5 JP 2022500119 A JP2022500119 A JP 2022500119A JP 2022500119 A JP2022500119 A JP 2022500119A JP 2022540396 A5 JP2022540396 A5 JP 2022540396A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- cells
- antigen
- nucleic acid
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025076885A JP2025124655A (ja) | 2019-07-05 | 2025-05-02 | 新規な癌抗原及び方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19184680 | 2019-07-05 | ||
| EP19184680.7 | 2019-07-05 | ||
| EP20170224 | 2020-04-17 | ||
| EP20170224.8 | 2020-04-17 | ||
| PCT/GB2020/051592 WO2021005338A2 (en) | 2019-07-05 | 2020-07-03 | Novel cancer antigens and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025076885A Division JP2025124655A (ja) | 2019-07-05 | 2025-05-02 | 新規な癌抗原及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022540396A JP2022540396A (ja) | 2022-09-15 |
| JP2022540396A5 true JP2022540396A5 (https=) | 2023-07-11 |
| JP7751817B2 JP7751817B2 (ja) | 2025-10-09 |
Family
ID=71523190
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022500119A Active JP7751817B2 (ja) | 2019-07-05 | 2020-07-03 | 新規な癌抗原及び方法 |
| JP2025076885A Pending JP2025124655A (ja) | 2019-07-05 | 2025-05-02 | 新規な癌抗原及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025076885A Pending JP2025124655A (ja) | 2019-07-05 | 2025-05-02 | 新規な癌抗原及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220213159A1 (https=) |
| EP (1) | EP3993826B1 (https=) |
| JP (2) | JP7751817B2 (https=) |
| KR (1) | KR20220034040A (https=) |
| CN (1) | CN114206913A (https=) |
| AU (1) | AU2020309202A1 (https=) |
| BR (1) | BR112022000020A2 (https=) |
| CA (1) | CA3142329A1 (https=) |
| IL (1) | IL289335A (https=) |
| MX (1) | MX2022000263A (https=) |
| WO (1) | WO2021005338A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021006941A2 (pt) | 2018-10-19 | 2021-08-31 | The Francis Crick Institute Limited | Antígenos de câncer inovadores e métodos |
| CA3179694A1 (en) * | 2020-04-17 | 2021-10-21 | The Francis Crick Institute Limited | Fusion proteins of ctl antigens for treating melanoma |
| JP2023522193A (ja) * | 2020-04-17 | 2023-05-29 | ザ フランシス クリック インスティチュート リミティッド | 抗原プール |
| WO2025202937A1 (en) | 2024-03-26 | 2025-10-02 | BioNTech SE | Cancer vaccines |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0871747A1 (en) | 1996-01-02 | 1998-10-21 | Chiron Viagene, Inc. | Immunostimulation mediated by gene-modified dendritic cells |
| US6770456B1 (en) | 1998-07-29 | 2004-08-03 | Ludwig Institute For Cancer Research | Endogenous retrovirus tumor associated nucleic acids and antigens |
| EP1586330A1 (en) | 2004-04-16 | 2005-10-19 | Georg-August-Universität Göttingen | Vaccination against malignant melanoma |
| DK1871391T3 (da) | 2005-03-30 | 2012-04-16 | Viroxis | Endogen retrovirus og proteiner, der kodes af env som target for cancerbehandling |
| WO2006105642A1 (en) * | 2005-04-05 | 2006-10-12 | British Columbia Cancer Agency | Biomarkers for the detection of lung cancer and uses thereof |
| AT502292B1 (de) * | 2005-05-11 | 2010-04-15 | Avir Green Hills Biotechnology | Melanomdiagnose |
| US8921050B2 (en) | 2006-03-17 | 2014-12-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of diagnosing renal cell carcinoma |
| US20080019979A1 (en) | 2006-05-22 | 2008-01-24 | Feng Wang-Johanning | HERV-K Antigens, Antibodies, and Methods |
| US8541553B2 (en) * | 2007-05-24 | 2013-09-24 | Baxter Healthcare Sa | Antibodies specific for the melanoma-associated endogenous retrovirus (MERV) envelope glycoprotein |
| NZ622148A (en) * | 2011-08-30 | 2016-06-24 | Nat Defense Medical Ct | Gene biomarkers for prediction of susceptibility of ovarian neoplasms and/or prognosis or malignancy of ovarian cancers |
| CN111655271B (zh) * | 2017-12-28 | 2025-09-23 | 隆萨销售股份公司 | 用于免疫肿瘤学和抗炎疗法的外来体 |
| CA3179694A1 (en) * | 2020-04-17 | 2021-10-21 | The Francis Crick Institute Limited | Fusion proteins of ctl antigens for treating melanoma |
-
2020
- 2020-07-03 AU AU2020309202A patent/AU2020309202A1/en not_active Abandoned
- 2020-07-03 BR BR112022000020A patent/BR112022000020A2/pt not_active IP Right Cessation
- 2020-07-03 KR KR1020217040819A patent/KR20220034040A/ko not_active Ceased
- 2020-07-03 WO PCT/GB2020/051592 patent/WO2021005338A2/en not_active Ceased
- 2020-07-03 JP JP2022500119A patent/JP7751817B2/ja active Active
- 2020-07-03 CN CN202080049314.4A patent/CN114206913A/zh active Pending
- 2020-07-03 MX MX2022000263A patent/MX2022000263A/es unknown
- 2020-07-03 CA CA3142329A patent/CA3142329A1/en active Pending
- 2020-07-03 EP EP20737269.9A patent/EP3993826B1/en active Active
-
2021
- 2021-12-17 US US17/644,938 patent/US20220213159A1/en active Pending
- 2021-12-23 IL IL289335A patent/IL289335A/en unknown
-
2025
- 2025-05-02 JP JP2025076885A patent/JP2025124655A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022540396A5 (https=) | ||
| Zeng et al. | Self-adjuvanting nanoemulsion targeting dendritic cell receptor Clec9A enables antigen-specific immunotherapy | |
| Senovilla et al. | Trial watch: DNA vaccines for cancer therapy | |
| CN107921111B (zh) | 用于各种癌症免疫治疗的新型肽、肽组合物和支架 | |
| Chesson et al. | Antigenic peptide nanofibers elicit adjuvant-free CD8+ T cell responses | |
| JP4185147B2 (ja) | Ｋｄｒペプチド及びこれを含むワクチン | |
| JP2022539585A5 (https=) | ||
| JP2022538609A5 (https=) | ||
| TW201720842A (zh) | 用於抗cll及其他癌症之免疫治療的新穎胜肽及胜肽組合物 | |
| CN118894905A (zh) | 子宫癌治疗 | |
| JP2022514116A5 (https=) | ||
| CN102947452A (zh) | 使用用于癌症的辅佐治疗的李斯特菌属的方法和组合物 | |
| CA3059644A1 (en) | Peptides and combination thereof for use in the immunotherapy against cancers | |
| CN103547283A (zh) | 前列腺相关抗原分子来源的人类白细胞抗原结合肽及其使用方法 | |
| CN106243213B (zh) | 一种肿瘤相关抗原XAGE-1b短肽及应用 | |
| JP2022539157A5 (https=) | ||
| US20230054958A1 (en) | Ctl peptide epitopes and antigen-specific t cells, methods for their discovery, and uses thereof | |
| JP4731867B2 (ja) | Ｃｄ８陽性の細胞傷害性ｔリンパ球の誘導方法 | |
| CN109970846A (zh) | 一种肿瘤相关抗原XAGE-1b九肽及其应用 | |
| JP2019537562A (ja) | 免疫原性アルギナーゼペプチド | |
| Kikuchi | Genetically modified dendritic cells for therapeutic immunity | |
| JP2011506497A5 (https=) | ||
| Nencioni et al. | Anticancer vaccination strategies | |
| JP2022501046A (ja) | アルギナーゼ１ポリペプチド | |
| CN104341530A (zh) | Vnsak多肽及其应用 |